NEW YORK (TheStreet) -- RATINGS CHANGES
Apple (AAPL - Get Report) was upgraded to buy from outperform at CLSA. Twelve-month price target is $695. Earnings momentum poised to accelerate with 300 million-plus iPhone installed base upgrade cycle, CLSA said.
Altera (ALTR) was downgraded to hold at TheStreet Ratings.
Athlon Energy (ATHL) was upgraded at Miller Tabak to buy. Twelve-month price target is $50. Acquisitions should add to earnings, Miller Tabak said.Ciena (CIEN) was upgraded at UBS to buy from neutral. Driven by strong optical product cycle, reasonable valuation and improved market position, UBS said. Twelve-month price target is $27. HMS (HMSY) was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $20. Stock has completely discounted the risk associated with an RAC renewal, Oppenheimer said. Microstrategy (MSTR) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $150. Management communication and visibility are improving, Deutsche Bank said. (MTB) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $136. Stock has lagged its peers and fears about the Hudson deal are overblown, Deutsche Bank said. ServiceNow (NOW) 12-month price target, EPS estimates were raised at UBS. Driven by huge billings growth with relatively little competition, UBS said. $70 price target and buy rating. Scotts Miracle-Gro (SMG) was upgraded at BMO Capital to outperform from market perform. Twelve-month price target is $67. Estimates were also increased following positive consumer surveys, BMO Capital said. (SIRI) was downgraded to hold at TheStreet Ratings. Xilinx (XLNX) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $50. Company may struggle to achieve guidance, Credit Suisse said.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts